Risedronate therapy for the prevention of steroid-induced osteoporosis in patients with minimal-change nephrotic syndrome.
Takei
Takashi
T
Department of Medicine, Kidney Center, Tokyo Women's Medical University. ttakei@kc.twmu.ac.jp
Itabashi
Mitsuyo
M
Tsukada
Misao
M
Sugiura
Hidekazu
H
Moriyama
Takahito
T
Kojima
Chiari
C
Shiohira
Shunji
S
Shimizu
Ari
A
Karasawa
Kazunori
K
Amemiya
Nobuyuki
N
Kawanishi
Kunio
K
Ogawa
Tetsuya
T
Uchida
Keiko
K
Tsuchiya
Ken
K
Nitta
Kosaku
K